Nasdaq
$0.5263▲ 3.54%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $8.4MShares out 16.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
56- 4d agoAfter-hours26.10.21 05:07DEFA14AOther#●●●
Tempest Therapeutics, Inc.
Tempest Therapeutics reconvened its special meeting of stockholders on October 14, 2026, but adjourned it to November 12, 2026, due to insufficient votes to approve the proposed charter amendments. The proposal aims to replace supermajority voting requirements and permit stockholder action by written consent, with the company engaging Sodali & Co. to assist in securing the necessary votes.…more
$0.5263+3.54%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 4d agoAfter-hours26.10.21 05:068-KKey event
Tempest Therapeutics, Inc.
Tempest Therapeutics reconvened its special meeting of stockholders on October 14, 2026, but adjourned it again to November 12, 2026, due to insufficient votes to approve the proposed amendment to its certificate of incorporation. The proposal aims to replace supermajority voting requirements and permit stockholder action by written consent, and the company is continuing efforts to secure the necessary 75% affirmative vote.…more
$0.5263+3.54%vs prev closeView filingShare - 5d agoAfter-hours26.10.20 05:058-KKey event
Tempest Therapeutics, Inc.
Tempest Therapeutics appointed John Frederick as an independent director, effective October 13, 2026. Mr. Frederick, a former CFO of Skillsoft and Indigo Ag, brings extensive expertise in financial strategy and capital markets to support the company's capital structure optimization and strategic growth.…more
$0.5263+3.54%vs prev closeView filingShare
55 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.14Pre-market26.10.14 21:00#●●●#●●●
Tempest Therapeutics Appoints John W. Frederick to Board of Directors
Tempest Therapeutics has appointed financial and capital markets expert John W. Frederick to its board of directors. The company expects his expertise to strengthen financial strategy and support disciplined capital deployment.…more
$0.5263+3.54%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.25After-hours26.09.26 05:37
●●●●●●●● ●●●●● ●●●●●●
Tempest Therapeutics has filed a prospectus to register the resale of up to 9,534,164 shares of common stock held by selling stockholders or issuable upon warrant exercise. This filing facilitates the potential future sale of these shares by existing holders and does not involve a new public offering.…more
$0.5263+3.54%vs prev closeShareBenzinga - 9.23Pre-market26.09.23 21:00
●●●●●●●● ●●●●● ●●●●●●
Clinical-stage biotech company Tempest Therapeutics has appointed finance and governance expert Nancy Freda-Smith as a new independent director and chair of the audit committee. The appointment is intended to strengthen the company's corporate governance and financial risk management.…more
$0.5263+3.54%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report